Additionally, heme degradation enzymes displayed an interesting contrasting pattern of isozyme BLVRA and BLVRB gene expression, indicating that normal hepatocytes and liver cancer lines utilize different processes for heme degradation. The gene discussed is BLVRA; the disease is liver cancer.